Long‐term Use of Somatostatin Analogue SMS 201–995 in the Treatment of Hypoglycaemia Due to Nesidioblastosis
- 1 May 1988
- journal article
- Published by Wiley in Acta Paediatrica
- Vol. 77 (3), 467-470
- https://doi.org/10.1111/j.1651-2227.1988.tb10683.x
Abstract
An infant presented with hypoglycaemia secondary to nesidioblastosis. Subtotal pancreatectomy failed to prevent recurrent post-operative hypoglycaemia. Subcutaneous somatostatin analogue (SMS 201-995) was shown to increase the blood concentrations of glucose and B-hydroxybutyrate while lowering serum insulin levels. Regular use of somatostatin analogue was helpful in long term management without causing significant side effects.Keywords
This publication has 6 references indexed in Scilit:
- Long-Term Treatment of an Infant with Nesidioblastosis Using a Somatostatin AnalogueNew England Journal of Medicine, 1987
- Treatment of insulin excess by continuous subcutaneous infusion of somatostatin and glucagon in an infantThe Journal of Pediatrics, 1985
- Nesidioblastosis of the pancreas: definition of the syndrome and the management of the severe neonatal hyperinsulinaemic hypoglycaemia.Archives of Disease in Childhood, 1981
- Somatostatin treatment of insulin excess due to β-cell adenoma in a neonateThe Journal of Pediatrics, 1980
- Hypoglycemia of Infancy and NesidioblastosisNew England Journal of Medicine, 1977
- Hyperinsulinism in Infants and Children: Diagnosis and Therapy*Advances in Pediatrics, 1976